Pediatric and neonatal testing kit market seen reaching $6.59B by 2030

The pediatric and neonatal testing kit market is projected to grow from $4.18 billion in 2025 to $4.55 billion in 2026, with long-range forecasts pointing to $6.59 billion by 2030. Growth is tied to broader newborn screening, molecular diagnostics, and rising demand from expanding infant and child populations.

Why it matters: - Pediatric and neonatal testing kits support earlier diagnosis and monitoring for newborns, infants and children. - The market’s growth signals more screening, faster testing and broader access to child-focused diagnostics. - Rising birth rates and expanded neonatal programs are increasing demand for these tools.

What happened: - The Business Research Company published its "Pediatric And Neonatal Testing Kit Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035." - The report puts the market at $4.18 billion in 2025 and $4.55 billion in 2026. - The report forecasts the market will reach $6.59 billion by 2030. - The report was released Aug. 22, 2026, in London. - Download a free sample of the report. - View the full market report.

The details: - The market is expected to grow at a 9.1% CAGR from 2025 to 2026. - The report projects a 9.7% CAGR through 2030. - Growth drivers include expanded neonatal screening programs, higher awareness of congenital conditions and advances in diagnostic assays. - The report also cites more pediatric healthcare facilities and greater reliance on hospital-based testing. - Longer-term growth is linked to precision pediatric diagnostics, investment in newborn health initiatives and wider use of molecular diagnostic tools. - Demand is also rising for rapid and portable testing kits and digital health monitoring in clinical workflows. - Key trends include more point-of-care testing for children, more dried blood spot screening, more combined genetic and metabolic testing, expanded newborn screening and earlier disease detection. - The kits are designed to diagnose and monitor newborns, infants and children. - Pediatricians, neonatologists, nurses and other clinical staff use the kits to support diagnosis, monitoring and treatment planning. - The report says growing neonatal and pediatric populations are a core market driver. - The Australian Bureau of Statistics reported 292,318 births in Australia in 2024, up 1.9% from 2023, including 150,299 males and 142,019 females. - North America held the largest share of the market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The forecast suggests pediatric diagnostics are moving from niche screening toward a more technology-enabled, routine part of care. - The emphasis on molecular tools, digital monitoring and portable kits points to demand for faster and more decentralized testing. - North America’s lead suggests advanced healthcare systems and stronger spending still give the region an early edge, even as other markets remain part of the growth story.

What's next: - The market is expected to keep expanding as newborn screening widens and precision diagnostics become more common. - Adoption of point-of-care and portable testing kits could reshape where and how children are tested. - More investments in newborn health initiatives and clinical digital tools may add further momentum.

The bottom line: - Pediatric and neonatal testing kits are set for steady growth, powered by more births, more screening and more advanced diagnostic technology.